Alx Oncology Holdings ALXO
NASDAQ ALXO
$1.12 +0.01 (+0.90%)
At close: Nov 11, 2026 · 4:00 PM EST

Alx Oncology Holdings (ALXO) Return on Equity [ROE] (2020 - 2026)

Updated

Alx Oncology Holdings (ALXO) posted Return on Equity [ROE] of -55.57% for Q2 2026, up 97.09 percentage points from -152.66% a year earlier and up 44.84 percentage points from the prior quarter.

Analysis

Alx Oncology Holdings (ALXO) Return on Equity [ROE] (2020 - 2026) Analysis & Trends

For FY2025, Alx Oncology Holdings' Return on Equity [ROE] came in at -145.70%, down 56.78 percentage points from FY2024.

  • Annual Return on Equity [ROE] has declined for four consecutive years, with a five-year change of -120.23 percentage points (FY2020 to FY2025).
  • In prior years, Alx Oncology Holdings' Return on Equity [ROE] was -88.91% in FY2024 (-17.95 pp), -70.97% in FY2023 (-31.55 pp), -39.42% in FY2022 (-18.37 pp) and -21.05% in FY2021 (+4.41 pp).
  • The Q2 2026 figure stands as the highest quarterly Return on Equity [ROE] since Q1 2023.
  • On a year-over-year basis, Return on Equity [ROE] increased in two of the last eight quarters, with an average year-over-year change of -34.28 percentage points.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q2 2026, with a gain of 97.09 percentage points; the weakest was Q4 2025, with a drop of 179.57 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -100.41% (Q1 2026), -287.25% (Q4 2025) and -197.76% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Alx Oncology Holdings 153.42 Mn -230.55 Mn - -55.57%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -55.57%
Mar 31, 2026 -100.41%
Dec 31, 2025 -287.25%
Sep 30, 2025 -197.76%
Jun 30, 2025 -152.66%
Mar 31, 2025 -128.77%
Dec 31, 2024 -107.68%
Sep 30, 2024 -102.06%
Jun 30, 2024 -105.96%
Mar 31, 2024 -93.90%
Dec 31, 2023 -89.76%
Sep 30, 2023 -76.59%
Jun 30, 2023 -57.56%
Mar 31, 2023 -51.27%
Dec 31, 2022 -44.84%
Sep 30, 2022 -40.19%
Jun 30, 2022 -33.48%
Mar 31, 2022 -26.56%
Dec 31, 2021 -22.32%
Sep 30, 2021 -18.68%
API Access

Alx Oncology Holdings Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ALXO&period=max&api_key=YOUR_API_KEY